
Nestle and Yellow Wood Partners Deal Makes the Sale of Supplement Brands for $1B
Nestle and the private equity firm Yellow Wood Partners have reached an agreement for a $1 billion acquisition deal. The
Nestle and the private equity firm Yellow Wood Partners have reached an agreement for a $1 billion acquisition deal. The Nestle and …
Dyson has entered the smart oral-care market. The new electric toothbrush by Dyson that combines a built-in camera, artificial intelligence (AI), sonic …
Novartis has temporarily halted eight clinical trials of its experimental CD19-targeted CAR-T therapy, rap-cel (YTB323), after three patients died from complications associated …
The pharma giant Eli Lilly is continuing its acquisition spree by adding another firm to the list. Eli Lilly has agreed to …
NHS England is introducing free finger-prick cholesterol tests at participating high-street pharmacies, giving eligible adults a quick way to check their cardiovascular …
Novo Nordisk’s oral Wegovy in China has moved a step closer to potential market entry after the country’s drug regulator accepted the …
The U.S. Food and Drug Administration (FDA) has approved Revolution Medicines’ once-daily pill, daraxonrasib, under the brand name Rasonque, for eligible adults …
McKesson has agreed to buy Precision Medicine Group for approximately $2.25 billion, expanding its presence in clinical research, drug development, and pharmaceutical …
The U.S. Food and Drug Administration (FDA) has approved the Roche and Eli Lilly’s Alzheimer’s blood test. This FDA approval is another …
A recent class-action case against America’s Retailer Kroger alleges that Kroger overcharged some insured customers for certain generic medications by failing to …
The Approval for Eli Lilly’s Insulin jab, Onswik, closer after The National Institute for Health and Care Excellence (NICE) has recommended Eli …
Merck and Moderna have announced a major advance in personalized cancer treatment after their investigational therapy met key goals in a late-stage …

Nestle and the private equity firm Yellow Wood Partners have reached an agreement for a $1 billion acquisition deal. The

Dyson has entered the smart oral-care market. The new electric toothbrush by Dyson that combines a built-in camera, artificial intelligence

Novartis has temporarily halted eight clinical trials of its experimental CD19-targeted CAR-T therapy, rap-cel (YTB323), after three patients died from

The pharma giant Eli Lilly is continuing its acquisition spree by adding another firm to the list. Eli Lilly has

NHS England is introducing free finger-prick cholesterol tests at participating high-street pharmacies, giving eligible adults a quick way to check

Novo Nordisk’s oral Wegovy in China has moved a step closer to potential market entry after the country’s drug regulator

The U.S. Food and Drug Administration (FDA) has approved Revolution Medicines’ once-daily pill, daraxonrasib, under the brand name Rasonque, for

McKesson has agreed to buy Precision Medicine Group for approximately $2.25 billion, expanding its presence in clinical research, drug development,

The U.S. Food and Drug Administration (FDA) has approved the Roche and Eli Lilly’s Alzheimer’s blood test. This FDA approval

A recent class-action case against America’s Retailer Kroger alleges that Kroger overcharged some insured customers for certain generic medications by

The Approval for Eli Lilly’s Insulin jab, Onswik, closer after The National Institute for Health and Care Excellence (NICE) has

Merck and Moderna have announced a major advance in personalized cancer treatment after their investigational therapy met key goals in